Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI Europe Health Care 20/35 Capped |
| Investment focus | Aandelen, Europa, Gezondheidszorg |
| Fund size | EUR 323 m |
| Total expense ratio | 0,17% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 16,68% |
| Inception/ Listing Date | 26 juni 2007 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxemburg |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH, Luxembourg Branch |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
| Revision Company | Ernst & Young S.A. |
| Fiscal Year End | 31 december |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% belastingvermindering |
| Switzerland | ESTV Reporting |
| Austria | Belastingrapportagefonds |
| UK | UK-rapportage |
| Italy | 26,0% |
| Indextype | Total return index |
| Swap counterparty | Deutsche Bank AG|Barclays Bank PLC|Société Générale|Merrill Lynch International|Goldman Sachs International|BNP Paribas|J.P. Morgan Securities plc|HSBC Bank Plc|Morgan Stanley Capital Services LLC|Citigroup Global Markets Limited |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Roche Holding AG | 16,86% |
| Novartis AG | 15,16% |
| AstraZeneca PLC | 13,30% |
| Novo Nordisk A/S | 7,99% |
| GSK Plc | 5,51% |
| Sanofi | 5,29% |
| argenx | 3,48% |
| EssilorLuxottica SA | 3,05% |
| Bayer AG | 3,00% |
| Lonza Group AG | 2,74% |
| Zwitserland | 42,92% |
| Verenigd Koninkrijk | 21,78% |
| Denemarken | 9,78% |
| Frankrijk | 9,59% |
| Anders | 15,93% |
| Gezondheidszorg | 94,98% |
| Consumentencyclische producten | 3,05% |
| Zakelijke dienstverlening | 0,52% |
| Financiën | 0,23% |
| Anders | 1,22% |
| YTD | +4.52% |
| 1 month | +5.75% |
| 3 months | +3.03% |
| 6 months | +4.13% |
| 1 year | +7.18% |
| 3 years | +17.79% |
| 5 years | +25.94% |
| Since inception (MAX) | +319.85% |
| 2025 | +4.06% |
| 2024 | +5.09% |
| 2023 | +10.05% |
| 2022 | -5.71% |
| Volatility 1 year | 16.68% |
| Volatility 3 years | 16.58% |
| Volatility 5 years | 16.04% |
| Return per risk 1 year | 0.43 |
| Return per risk 3 years | 0.34 |
| Return per risk 5 years | 0.29 |
| Maximum drawdown 1 year | -12.34% |
| Maximum drawdown 3 years | -27.29% |
| Maximum drawdown 5 years | -27.29% |
| Maximum drawdown since inception | -34.62% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | DXSE | - - | - - | - |
| London Stock Exchange | GBX | XSDR | XSDR LN XSDRINAV | XSDR.L XSDRNAV.DE | |
| Börse Stuttgart | EUR | DXSE | XSDR GS | XSDR.SG | |
| XETRA | EUR | DXSE | DXSE GY | DXSE.DE |
| Fondsname | Fondsgröße in Mio. € (AuM) | TER p.a. | Ausschüttung | Replikation |
|---|---|---|---|---|
| iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) | 887 | 0,18% p.a. | Thesaurierend | Vollständig |
| State Street SPDR MSCI Europe Health Care UCITS ETF EUR | 599 | 0,18% p.a. | Thesaurierend | Vollständig |